Day 2: Wednesday, March 18th, 2026Wednesday, 18 March 2026 - EST/EDT (Eastern Daylight, GMT-4)

Navigate the complex landscape of demonstrating program value and securing leadership support for your patient services initiatives. Learn effective strategies to measure success, manage change and align goals across your organization.

• Establish meaningful metrics that showcase the true value of your patient services program

• Master the art of managing up to secure additional resources and executive support

• Implement change management strategies that drive adoption and alignment across departments

• Connect patient services goals with broader organizational objectives to demonstrate strategic value

Address the dual challenges of data accuracy and infrastructure management that manufacturers face when working with specialty pharmacies and internal teams. Explore comprehensive strategies for creating a data ecosystem that drives operational efficiency while ensuring integrity across the patient journey.

• Identify best practices to ensure data accuracy from specialty pharmacy partners and overcome system lags

• Design robust data governance frameworks that define appropriate access levels across commercial, medical and analytics teams

• Establish a solid data strategy foundation with effective data sources and dedicated management resources

• Develop balanced approaches to data interpretation and segmentation that maintain quality while enabling timely insights and action

Discover innovative approaches to leverage your hub data beyond basic reporting to create meaningful patient interactions. Learn how to use data insights to enhance patient experiences and drive better outcomes.

• Profile patients effectively to enable more meaningful and timely interventions

• Identify key touchpoints in the patient journey where data-driven interventions can make the greatest impact

• Design personalized support programs based on patient-specific data insights

In 2025, the gap between pharmaceutical manufacturers and patients narrowed significantly with the rise of direct-to-patient (DTP) programs and increasing regulatory pressures. In 2026, industry-leading DTP programs are evolving beyond regulatory safety nets into strategic assets for patient outcome optimization. When done right, DTP is more than an operational channel, it’s a win-win for patients and pharma – these programs can be data-driven growth engines with the power to solve the industry’s most persistent friction points and maximize access, affordability, adherence, and trust. Join seasoned leaders as they discuss the next generation of DTP models to drive exceptional experiences and measurable impact for patients.

• Navigating today’s complex regulatory pressures, competitive landscape and market dynamics effectively to build next-generation DTP programs that are the optimal fit for patients and brands
• Building customized DTP programs – determining whether a cash, coverage or hybrid model is best – to create a modern patient experience designed to maximize access, affordability, adherence and trust
• Elevating data and analytics frameworks to accurately measure and optimize the success of DTP programs on patient outcomes and brand performance

Evaluate the strategic considerations of bringing your hub operations in-house for greater control over the patient experience. This session explores the benefits, challenges and implementation strategies for internal/hybrid hub models.

• Assess the business case for insourcing versus outsourcing hub operations

• Develop the infrastructure needed to support internal hub operations

• Build the right team with specialized skills for patient support excellence

• Create hybrid models that balance control with external expertise

Manufacturers invest heavily in patient support, yet access delays, treatment abandonment and inconsistent patient experiences persist. The issue is not program design or effort: it is a growing system design gap inside health systems. In this session, we explore how forward-thinking health systems are moving from access chaos to orchestration by building centralized patient access and affordability operating models. Attendees will gain visibility into what is actually changing downstream, how these models improve predictability for patients and providers and why manufacturer programs land more effectively when access is coordinated rather than fragmented.

• Why access challenges persist despite strong manufacturer hub and patient support investments

• What “centralized patient access and affordability” looks like inside modern health systems

• How fragmented access environments create hidden friction for manufacturer programs

• Why orchestration (not more programs) is becoming the missing layer in specialty access that could unlock full value

• How manufacturers can better align with health systems that are building access infrastructure to improve patient experience and program effectiveness

In patient services, timing, access and coordination are everything. Patients depend on care teams who can move quickly, educate compassionately and navigate complex reimbursement pathways with confidence. This session explores the value of relaunch and how to apply new thinking to old problems in patient services.

• Mounting a rapid response team to get patients on treatment immediately

• Adapting a clinical navigator program to improve adherence through high-touch education

• Using data to anticipate barriers and drive faster payor approval

Discover untapped opportunities to engage patients through pharmacy partnerships. Learn how specialty pharmacies can extend your hub capabilities and enhance the patient experience.

• Leverage pharmacy touchpoints to drive patient program enrollment and engagement

• Develop collaborative models with specialty pharmacies for patient education

• Create "hub-lite" solutions through pharmacy partnerships for products with limited services

• Measure the impact of pharmacy-based patient engagement initiatives

Gain insights into current enforcement priorities for patient support programs. Hear from DOJ directly to discuss actions and trends that are shaping patient access.

• Understand current enforcement actions and their implications for program design

• Anticipate shifts in enforcement priorities under the current administration

• Navigate compliance considerations for newer patient support models

• Implement best practices for program documentation and oversight